minktherapeutics.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi INKT

Logo grafis MiNK Therapeutics Inc. (INKT)

The success of MiNK Therapeutics, Inc. (INKT) is based on the efficacy of iNKT cells and the scaling of agenT-797, as well as the establishment of scientific alliances with oncology centers. EBITDA fluctuations over the time trajectory on the GURU.Markets chart demonstrate the influence of these factors, with the metric recorded at 0.00. The security of intellectual property and the humanitarian status of the therapy in the US minimize geopolitical risks.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: MiNK Therapeutics, Inc. (INKT) kanggo 23.11.2025 - 17.11.2026

MiNK Therapeutics Inc. - rincian analitis lan metrik utama (INKT)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:minktherapeutics.com - INKT
Produk seri MiNK Therapeutics

This metric measures net cash flow from operating activities before accounting for asset depreciation and debt obligations, determining the business's actual capacity for resource generation. In the context of MiNK Therapeutics, Inc. (INKT), the EBITDA_Co valuation reflects clinical trial progress rather than market cycles, allowing investors to differentiate the company's fundamental growth from speculative share price volatility.

Pesaing MiNK Therapeutics, Inc. (INKT)

ImmunityBio (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (Janux Therapeutics, Inc.)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi tangotx.com|Bathi operasional sadurunge ngurangi amortisasi iovance.com (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics NV (IMTX)|Bathi operasional sadurunge ngurangi amortisasi Xencor Corp XNCR|Compass Therapeutics Inc - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Inc. REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (innate-pharma.com) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen Ltd. (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HOWL (Werewolf Therapeutics)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi IMMX|Bathi operasional EBITDA ALXO (ALX Oncology)|cuebiopharma.com (CUE) - Bathi sadurunge bunga, pajak, lan amortisasi|PDS Biotechnology Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Liminatus Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LVTX (Lava Tx) - Bathi operasional EBITDA|Bathi operasional EBITDA NextCure Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi leaptx.com (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Biologics (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|gritstonebio.com - Bathi operasional EBITDA|KA (Kineta) - Bathi operasional sadurunge amortisasi|NEXI: Bathi operasional EBITDA|Turnstone Biologics Corporation (TSBX) - Bathi operasional EBITDA|VCNX (vaccinex.com) - Bathi operasional EBITDA|HARP: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi